Retrospective analysis of disease profile and percentage of COVID positivity among patients presenting to paediatric triage of a tertiary care hospital during COVID pandemic lockdown period
DOI:
https://doi.org/10.18203/2349-3291.ijcp20211677Keywords:
COVID-19, Paediatric, Tertiary care centre, OPD attendance, ImmunizationAbstract
Background: Currently, limited reports analyze pediatric patients infected with SARS-Covid-19. We conducted this study with the purpose of assessing the disease profile and percentage of COVID positivity among pediatric patients presenting to our triage area.
Methods: A retrospective quantitative observational study was conducted in the pediatric triage area, department of pediatrics, Civil hospital campus, Ahmedabad, India. Patients aged 0-12 years were included with the study period from 1stApril to 30th June, 2020. Patients fulfilling the ICMR testing criteria were considered as suspected COVID patients and tested for COVID. Remaining patients were triaged and managed either on OPD basis or admitted in PICU, NICU or pediatric ward. Also, data of OPD attendance rate and immunization rates of 3 months (April, May and June) of 2019 and 2020 were collected from pediatric OPD and vaccination center.
Results: A total of 709 patients presented in the triage out of which 35.5% were neonates, 28.6% were between 1-12 month, 23.2%were between 1-5 years and 12.6% were between 5-12 years. 12 out of 97 suspected patients tested positive for COVID 19. Among COVID positive patients, 50% had uncomplicated illness or mild pneumonia, while 50 % had critical illness and were admitted in COVID ICU. Mortality among non COVID patients was 22.7%, and among COVID patients was 16.6%. A sharp fall was noted in the OPD attendance (10 times) and immunization rates (3 times) this year compared to last year.
Conclusions: Incidence of COVID positivity was comparable to the studies done in other countries. Even during the pandemic peak, the major chunk of pediatric admissions still belonged to the non COVID conditions. The drastic fall in immunization rates can have implications in the form of re-emergence of vaccine preventable diseases in the coming times.
References
Centres for disease control and prevention. Novel Coronavirus, Wuhan, China, 2019. Available at https://www.cdc.gov/coronavirus/2019-ncov/about/index.html. Accessed on 27 February 2021.
Gallegos A. WHO Declares Public Health Emergency for Novel Coronavirus. Medscape Medical News, 2020. Available at: https://www.medscape.com/viewarticle/924596. Accessed on 27 February 2021.
Wee SL, Donald G. McNeil, Javier C. W.H.O. Declares Global Emergency as Wuhan Coronavirus Spreads. Available at: at https://nyti.ms/2RER70M. Accessed on 27 February 2021.
The New York Times. Coronavirus Live Updates: W.H.O. Declares Pandemic as Number of Infected Countries Grows, 2020. Available at: https://www.nytimes.com/2020/03/11/world/coronavirus-news.html#link-682e5b06. Accessed on 27 February 2021.
Gorbalenya AE, Baker SC, Baric RS, Groot RJ, Drosten C, Anastasia A, et al. Severe acute respiratory syndrome-related coronavirus: The species and its viruses–a statement of the Coronavirus Study Group. bioRxiv. 2020;937862.
Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-42.
Centres for disease control and prevention. 2019 Novel Coronavirus, Wuhan, China: Symptoms, 2021. Available at: https://www.cdc.gov/coronavirus/2019-ncov/about/symptoms.html. Accessed on 27 February 2021.
The New York Times. Coronavirus Updates: The Illness Now Has a Name: COVID-19, 2020. Available at https://www.nytimes.com/2020/02/11/world/asia/coronavirus-china.html. Accessed on 27 February 2021.
WHO Director. General's remarks at the media briefing on 2019-nCoV, 2020. Available at https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020. Accessed on 27 February 2021.
Novel coronavirus (2019-nCoV) situation report 5. Available at: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200125-sitrep-5-2019-ncov.pdf?sfvrsn=429b143d_8. Accessed on 20 February 2021.
Centres for disease control and prevention. Coronavirus Disease 2019 (COVID-19): Recommendations for Cloth Face Covers. Centers for Disease Control and Prevention, 2020. Available at: https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/cloth-face-cover.html. Accessed on 27 February 2021.
Centres for disease control and prevention. Coronavirus Disease 2019 (COVID-19): COVID-19 Situation Summary, 2020. Available at: https://www.cdc.gov/coronavirus/2019-ncov/summary.html. Accessed on 27 February 2021.
CDC COVID-19 Response Team. Coronavirus Disease 2019 in Children - United States, February 12-April 2, 2020. MMWR Morb Mortal Wkly Rep. 202;69(14):422-6.
Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, et al. Epidemiology of COVID-19 Among Children in China. Pediatrics. 2020;145(6):20200702.
Livingston E, Bucher K. Coronavirus Disease 2019 (COVID-19) in Italy. JAMA. 2020;323(14):1335.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review. J Am Med Assoc Pediatr. 2020.
Tagarro A, Epalza C, Santos M, Sanz-Santaeufemia FJ, Otheo E, Moraleda C, et al. Screening and Severity of Coronavirus Disease 2019 (COVID-19) in Children in Madrid, Spain. JAMA Pediatr. 2020:201346.
WHO. Coronavirus (COVID-19) Dashboard, 2021. Available at: https://covid19.who.int. Accessed on 27 February 2021.
Ministry of Health and Family Welfare Directorate General of Health Services. Revised Guidelines on Clinical Management of COVID-19, 2020. Available at: https://www.mohfw.gov.in/pdf/RevisedNationalClinicalManagementGuidelineforCOVID1931032020.pdf. Accessed on 27 February 2021.